Portfolio company
Insamo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops a platform to discover orally available cyclic peptides for pharmaceutical organisations seeking alternatives to injectable biologic medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
Nexos
Nexos Biosciences develops exosome-based drug delivery systems for pharmaceutical companies to enable oral administration of treatments for cancer, inflammation, and metabolic diseases.
Ladder Bio
This biotechnology company develops ladder-shaped therapeutic molecules to provide pharmaceutical partners with oral medicines for targets that are currently difficult to drug.
Orbit Discovery
The company provides a peptide display platform for biotechnology and pharmaceutical partners to identify and optimise lead compounds for novel therapeutic drug development.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
